Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | CHYM | VNRFY |
|---|---|---|
| Price | $28.29 | $16.75 |
| Change today | ▲ 3.82% | ▲ 0.00% |
| Market cap | $10.71B | $10.72B |
| Return, 3 months | +33.9% | +11.9% |
| Return, year to date | +12.4% | +7.3% |
| Return, 1 year | +34.4% | +74.3% |
| P/E (TTM) | -589.4 | 6.7 |
| P/B | 7.6 | 1.3 |
| P/E percentile vs own 5y | – | – |
| Dividend yield | – | 2.40% |
| Revenue growth (YoY, latest qtr) | – | – |
| Net profit growth (YoY) | – | – |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | – |
| Return on equity | – | – |
| Analyst target vs. price | – | – |
| Analyst buy share | – | – |
| RSI (14) | 45 | 82 |
| 30-day volatility | 52.3% | 34.1% |
| Max drawdown, 1 year | -41.1% | -16.4% |
| Trend read | Leaning bearish | Strong uptrend |
| Analyst consensus | – | – |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
